Ten Things Health Execs Should Know about Lymphoma

A new indication, a nonprescription switch, a recall, and new guidances round out this week’s FDA news.

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

How a tool is helping execs define and measure value in oncology.

Top oncology experts share how they deliver these therapies to patients in need.

With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.

New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.